Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T19:36:13.640Z.
Calculation as of: 2026-10-06T19:36:13.640Z.
Quote observation: 2026-10-06T19:34:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f1b6469add1457cabf137e6e5cfb012e486d3d2c84b47330ed8a9effb8bf14c7
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$66.01M
Free Cash Flow Yield
N/A
TTM Avg
24.06%
3Y Avg
24.06%
5Y Avg
24.06%
Market Cap
$69.05M
Free Cash Flow Yield
N/A
TTM Avg
6.20%
3Y Avg
5.62%
5Y Avg
4.88%
Market Cap
$65.17M
Free Cash Flow Yield
N/A
TTM Avg
2.91%
3Y Avg
2.91%
5Y Avg
2.91%
Market Cap
$68.60M
Free Cash Flow Yield
183.45%
TTM Avg
137.42%
3Y Avg
137.42%
5Y Avg
137.42%
Market Cap
$68.68M
Free Cash Flow Yield
28.51%
TTM Avg
14.79%
3Y Avg
25.02%
5Y Avg
20.90%
Market Cap
$68.72M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cingulate Inc. (CING) | $66.13M | N/A | N/A | N/A | N/A |
| iBio, Inc. (IBIO)vs › | $66.24M | N/A | N/A | N/A | N/A |
| XBiotech Inc. (XBIT)vs › | $66.01M | N/A | 24.06% | 24.06% | 24.06% |
| Champions Oncology, Inc. (CSBR)vs › | $69.05M | N/A | 6.20% | 5.62% | 4.88% |
| Gossamer Bio, Inc. (GOSS)vs › | $65.17M | N/A | 2.91% | 2.91% | 2.91% |
| Fortress Biotech, Inc. (FBIO)vs › | $68.60M | 183.45% | 137.42% | 137.42% | 137.42% |
| Spero Therapeutics, Inc. (SPRO)vs › | $68.68M | 28.51% | 14.79% | 25.02% | 20.90% |
| Tiziana Life Sciences Ltd (TLSA)vs › | $68.72M | N/A | N/A | N/A | N/A |
| Alps Group Inc (ALPS)vs › | $63.56M | N/A | N/A | N/A | N/A |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.16M | N/A | 3.20% | 3.20% | 3.20% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
